Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.54 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.54 |
| ▸ | PDE4A | P27815 | 1/20 | 0.54 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.54 |
| ▸ | PPARA | Q07869 | 11/20 | 0.36 |
| ▸ | PPARG | P37231 | 10/20 | 0.36 |
| ▸ | PPARD | Q03181 | 9/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24939697 | 0.86 | TDP1 (0.60) | TDP1CHRM1TBXA2RPDE4AADRA1A | |
| SCHEMBL24939797 | 0.82 | TDP1 (0.61) | TDP1CHRM1TBXA2RPDE4AADRA1A | |
| SCHEMBL24939799 | 0.80 | TDP1 (0.55) | TDP1CHRM1TBXA2RPDE4AADRA1A | |
| Iolidonic Acid SCHEMBL2110121 | 0.80 | CYP1A2 (0.57) | TDP1CHRM1TBXA2RPDE4AADRA1A | |
| SCHEMBL24939699 | 0.72 | TSHR (0.35) | — | |
| Iophenoxic Acid SCHEMBL966564 | 0.72 | TDP1 (1.00) | TDP1CHRM1TBXA2RPDE4AADRA1A | |
| Iopanoic Acid SCHEMBL38976 | 0.71 | LMNA (1.00) | TDP1CHRM1TBXA2RPDE4AADRA1A | |
| Iopanoic Acid SCHEMBL29358912 | 0.71 | LMNA (1.00) | TDP1CHRM1TBXA2RPDE4AADRA1A | |
| SCHEMBL10495750 | 0.69 | CYP1A2 (0.70) | TDP1CHRM1TBXA2RPDE4AADRA1A | |
| SCHEMBL11373524 | 0.68 | TDP1 (0.66) | TDP1CHRM1TBXA2RPDE4AADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230022129-A1 | RESIST MATERIAL AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230022129-A1 | RESIST MATERIAL AND PATTERNING PROCESS | GFER, LBR, PCNA | TDP1 4541/4885CHRM1 4133/4885TBXA2R 4593/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.